Sign In
Buy CERE
$44.96
+0 (+0%)
At Close: Oct 30, 2024
3 Stocks Insiders Are Buying
08:16am, Wednesday, 01'st Sep 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
New York, New York--(Newsfile Corp. - August 12, 2021) - Levi & Korsinsky announces it has commenced an investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) concerning possible breaches
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q2 2021 Results - Earnings Call Transcript
01:01pm, Wednesday, 11'th Aug 2021
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q2 2021 Results - Earnings Call Transcript
Cerevel Therapeutics Reports Second Quarter 2021 Financial Results and Business Updates
06:30am, Wednesday, 11'th Aug 2021
Announced positive topline results for CVL-231 in Phase 1b trial in schizophrenia
New York, New York--(Newsfile Corp. - August 2, 2021) - Levi & Korsinsky announces it has commenced an investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) concerning possible breaches
Why Cerevel Therapeutics Is Up More Than 29% in the First Half of 2021
07:20pm, Monday, 19'th Jul 2021
A positive early stage trial for a schizophrenia drug has pushed this biotech's stock this year.
Here's What's Pushing Cerevel Therapeutics Stock Lower Today
02:28pm, Friday, 02'nd Jul 2021
Investors aren't thrilled about how this biotech intends to pay operating expenses that are about to balloon.
Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock
09:50pm, Thursday, 01'st Jul 2021
CAMBRIDGE, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today th
CERE Stock: The Huge News That Has Cerevel Therapeutics Skyrocketing
03:20pm, Tuesday, 29'th Jun 2021
Cerevel Therapeutics is taking on schizophrenia with its newest drug treatment. After posting positive trial results, CERE stock is up big.
These 2 Nasdaq Biotechs Made Eye-Popping Moves Tuesday
01:49pm, Tuesday, 29'th Jun 2021
You might not have heard of them, but one went up big while the other served up a massive disappointment.
Here's Why Cerevel Therapeutics Stock Is Shooting Through the Roof Today
12:35pm, Tuesday, 29'th Jun 2021
Positive topline results from the company's schizophrenia candidate were better than expected.
CERE Stock Price Increases Over 60% Pre-Market: Why It Happened
08:17am, Tuesday, 29'th Jun 2021
The stock price of Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) increased by over 60% pre-market. This is why it happened.
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q1 2021 Results - Earnings Call Transcript
11:52am, Monday, 17'th May 2021
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q1 2021 Results - Earnings Call Transcript
Cerevel Therapeutics Reports First Quarter 2021 Financial Results and Business Updates
06:30am, Monday, 17'th May 2021
Announced strategic $125 million non-dilutive financing for tavapadon
Cerevel Therapeutics Appoints Abraham N. Ceesay as President
07:00am, Wednesday, 21'st Apr 2021
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced the appointme
